网络药理学联合代谢组学探究疏清颗粒治疗甲型H1N1流感的作用机制

张思宇 ,  孟窈 ,  王紫嫣 ,  王国强 ,  王放 ,  董智勇

国际老年医学杂志 ›› 2026, Vol. 47 ›› Issue (6) : 527 -534.

PDF (4100KB)
国际老年医学杂志 ›› 2026, Vol. 47 ›› Issue (6) : 527 -534. DOI: 10.3969/j.issn.1674-7593.2026.06.005
论著

网络药理学联合代谢组学探究疏清颗粒治疗甲型H1N1流感的作用机制

作者信息 +

Exploring the mechanism of Shuqing Granule in treating Influenza A (H1N1) based on network pharmacology combined with metabolomics

Author information +
文章历史 +
PDF (4197K)

摘要

目的 联合网络药理学和代谢组学探究疏清颗粒 (SG) 抗甲型 H1N1 流感的作用机制。方法 筛选 SG 和甲型流感相关靶点, 构建蛋白质互作 (PPIs) 网络并进行通路富集; 建立甲型 H1N1 流感小鼠模型, 实时荧光定量 PCR (RT-qPCR) 检测炎性因子表达情况; 苏木素-伊红染色观察肺部病理变化; 非靶向代谢组学分析血清差异代谢物及相关通路。结果 筛选出 SG 抗流感靶点 114 个, 富集到 Influenza A、 肿瘤坏死因子 (TNF) 和核因子 (NF) -κB 等核心通路; SG 干预后小鼠肺部炎性因子的 mRNA 表达量显著降低, 炎症浸润明显改善; 血清代谢组学鉴定出 48 个差异代谢物, 联合分析得到 5 条代谢通路。结论 SG 可能通过花生四烯酸、 槲皮素等活性成分靶向炎症通路, 调控代谢相关过程, 减轻甲型 H1N1 流感引发的肺部炎症。

Abstract

Objective To explore the anti-influenza A (H1N1) mechanism of Shuqing Granules (SG) by combining network pharmacology and metabolomics. Methods Targets related to SG and influenza were screened, followed by the construction of a protein-protein interaction (PPIs) network and pathway enrichment analysis. A mouse model of Influenza A (H1N1) infection was established, and the expression of inflammatory factors was detected by real-time quantitative polymerase chain reaction (RT-qPCR). Pulmonary pathological changes were observed by hematoxylin-eosin staining, and serum differential metabolites and related pathways were analyzed by untargeted metabolomics. Results A total of 114 anti-influenza targets of SG were identified, which were significantly enriched in core pathways such as Influenza A, tumor necrosis factor (TNF) and nuclear factor (NF) -κB signaling pathways. After the SG intervention, the mRNA expression levels of inflammatory factors in mice were markedly downregulated, and inflammatory infiltration in lung tissues was significantly ameliorated. Untargeted metabolomics identified 48 differential metabolites in serum, and 5 metabolic pathways were obtained through integrated analysis. Conclusion SG may target inflammatory pathways via active components such as arachidonic acid and quercetin, regulate metabolism-related processes, and thereby alleviate pulmonary inflammation induced by Influenza A (H1N1) infection.

关键词

甲型 H1N1 流感病毒 / 肺炎 / 疏清颗粒 / 代谢组学 / 细胞因子风暴

Key words

Influenza A (H1N1) virus / Viral pneumonia / Shuqing Granules / Metabolomics / Cytokine storm

引用本文

引用格式 ▾
张思宇,孟窈,王紫嫣,王国强,王放,董智勇. 网络药理学联合代谢组学探究疏清颗粒治疗甲型H1N1流感的作用机制[J]. 国际老年医学杂志, 2026, 47(6): 527-534 DOI:10.3969/j.issn.1674-7593.2026.06.005

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

Jain R, Sharma H, Pena L, et al. Influenza virus: genomic insights, evolution, and its clinical presentation [J]. Microb Pathog, 2025, 205: 107671.

[2]

Xi S, Li Y, Yue L, et al. Role of Traditional Chinese Medicine in the management of viral pneumonia [J]. Front Pharmacol, 2020, 11: 582322.

[3]

Pagliano P, Sellitto C, Conti V, et al. Characteristics of viral pneumonia in the COVID-19 era: an update[J]. Infection, 2021, 49(4): 607-616.

[4]

Kumari R, Sharma S D, Kumar A, et al. Antiviral approaches against influenza virus[J]. Clin Microbiol Rev, 2023, 36(1): e0004022.

[5]

Barrett D. IL-6 blockade in cytokine storm syndromes [J]. Adv Exp Med Biol, 2024, 1448: 565-572.

[6]

Gu Y, Hsu A C, Pang Z, et al. Role of the innate cytokine storm induced by the Influenza A virus[J]. Viral Immunol, 2019, 32(6): 244-251.

[7]

Bai Y, Liu T, Zhang S, et al. Traditional Chinese Medicine for viral pneumonia therapy: pharmacological basis and mechanistic insights [J]. Int J Biol Sci, 2025, 21(3): 989-1013.

[8]

张思宇. 基于网络药理学和代谢组学探究疏清颗粒对 H1N1 流感病毒感染小鼠的保护作用及机制[D]. 长春: 吉林大学, 2023.

[9]

Zhang S Y. Protective effect and mechanism of Shuqing Granules on H1N1 Influenza virus-infected mice based on network pharmacology and metabolomics [D]. Changchun: Jilin University, 2023.

[10]

Guo X, Zheng H, An Y, et al. Network pharmacology and experiment verification-based strategy for exploring the mechanisms of Shuqing Granule in the treatment of COVID-19[J]. Pharmaceuticals (Basel), 2025, 18(8): 1216.

[11]

呼洁, 王鑫磊, 张超, 等. 疏清颗粒对 EV71 的体外抗病毒研究[J]. 湖南中医药大学学报, 2013, 33(12): 3, 7.

[12]

Hu J, Wang X L, Zhang C, et al. The antiviral activity of Shu Qing granules against enterovirus 71 in vitro[J]. J Tradit Chin Med Univ Hunan, 2013, 33(12): 3, 7.

[13]

Yuan Y, Wang C, Wang G, et al. Airway microbiome and serum metabolomics analysis identify differential candidate biomarkers in allergic rhinitis[J]. Front Immunol, 2021, 12: 771136.

[14]

Raza M A, Ashraf M A, Amjad M N, et al. The peculiar characteristics and advancement in diagnostic methodologies of Influenza A virus[J]. Front Microbiol, 2024, 15: 1435384.

[15]

Jones J C, Yen H L, Adams P, et al. Influenza antivirals and their role in pandemic preparedness[J]. Antiviral Res, 2023, 210: 105499.

[16]

吴文玉, 吴鹏, 李诺然, 等. 中医药治疗流行性感冒的研究进展[J]. 南京中医药大学学报, 2025, 41(11): 1613-1632.

[17]

Wu W Y, Wu P, Li N R, et al. Research progress of Traditional Chinese Medicine in the treatment of influenza [ J ]. J Nanjing Univ Chin Med, 2025, 41 (11 ): 1613-1632.

[18]

李葆林, 麻景梅, 田宇柔, 等. 甘草中新发现化学成分和药理作用的研究进展[J]. 中草药, 2021, 52(8): 2438-2448.

[19]

Li B L, Ma J M, Tian Y R, et al. Research progress on newly discovered chemical components and pharmacological effects in Glycyrrhiza uralensis[J]. Chin Tradit Herb Drugs, 2021, 52(8): 2438-2448.

[20]

孙经梦, 刘骏, 李炯, 等. 桑叶提取物对小鼠感染甲型流感病毒 FM1 的预防与治疗作用研究[J]. 中药材, 2013, 36(11): 1837-1842.

[21]

Sun J M, Liu J, Li J, et al. Protective and therapeutic effects of mulberry leaf extract on mice infected with Influenza A virus FM1[J]. J Chin Med Mater, 2013, 36(11): 1837-1842.

[22]

冯琦, 刘义钢, 何琴, 等. 大青叶水提物对牛传染性鼻气管炎病毒的体外增殖抑制活性评价[J]. 畜牧兽医学报, 2024, 55(11): 5287-5298.

[23]

Feng Q, Liu Y G, He Q, et al. Evaluation of the inhibitory activity of folium isatidis aqueous extract on the in vitro proliferation of infectious bovine rhinotracheitis virus [J]. Acta Veterinaria Et Zootechnica Sinica, 2024, 55(11): 5287-5298.

[24]

王紫嫣. 基于 MAPK 信号通路探究疏清颗粒抗甲型流感病毒 H1N1 的作用[D]. 长春: 吉林大学, 2019.

[25]

Wang Z Y. Anti-influenza A virus H1N1 effect of Shuqing Granules based on MAPK signaling pathway[ D]. Changchun:Jilin University, 2019.

[26]

李文斌, 杨春, 李洁, 等. 槲皮素治疗肺部感染的药理作用研究进展[J]. 现代药物与临床, 2025, 40(10): 2666-2671.

[27]

Li W B, Yang C, Li J, et al. Research progress on pharmacological effects of quercetin in treatment of pulmonary infections[J]. Drugs & Clinic, 2025, 40(10): 2666-2671.

[28]

Liu Q, Bengmark S, Qu S . Nutrigenomics therapy of hepatisis C virus induced-hepatosteatosis[J]. BMC Gastroenterol, 2010, 10: 49.

[29]

Yuan S, Jiang S C, Zhang Z W, et al. Quantification of cytokine storms during virus infections[J]. Front Immunol, 2021, 12: 659419.

[30]

Morris G, Bortolasci C C, Puri B K, et al. The cytokine storms of COVID-19, H1N1 Influenza, CRS and MAS compared. Can one sized treatment fit all? [J]. Cytokine, 2021, 144: 155593.

[31]

Cesaro T, Michiels T . Inhibition of PKR by Viruses[J]. Front Microbiol, 2021, 12: 757238.

[32]

Sietsema W K, Kelm G R, Deibel R M, et al. Absorption, bioavailability, and pharmacokinetics of tebufelone in the rat[J]. J Pharm Sci, 1993, 82(6): 610-612.

[33]

Song Y, Hai E, He L, et al. Linoleic acid metabolite 13-Hydroxyoctadecadienoic acid as a biphasic ferroptosis modulator in granulosa cells: multi-omics analysis of ovine atretic follicles [J]. Front Cell Dev Biol, 2025, 13: 1610621.

[34]

Sala A, Proschak E, Steinhilber D, et al. Two-pronged approach to anti-inflammatory therapy through the modulation of the arachidonic acid cascade[J]. Biochem Pharmacol, 2018, 158: 161-173.

基金资助

*吉林省科技发展计划项目(20210401084YY)

AI Summary AI Mindmap
PDF (4100KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉